Rang	Name	Position
1	Mr. Christopher M. Hall	CEO & Director
2	Dr. Richard Chen M.D., M.S.	President & Chief Medical Officer
3	Mr. Aaron L. Tachibana	CFO & COO
4	Dr. Russ B. Altman M.D., Ph.D.	Co-Founder and Member of Clinical & Scientific Advisory Board
5	Dr. Euan Angus Ashley DPHIL, FRCP, M.D., Ph.D.	Co-Founder and Member of Clinical & Scientific Advisory Board
6	Dr. Michael P. Snyder Ph.D.	Co-Founder and Member of Clinical & Scientific Advisory Board
7	Mr. Ashish Kheterpal	Senior VP & Chief Information Officer
8	Mr. Stephen M. Moore J.D.	Senior VP, Chief Legal Officer & Corporate Secretary
9	Dr. Christian Haudenschild Ph.D.	Senior Vice President of Genomic Science
10	Mr. Stephane Mouradian Ph.D.	Senior Vice President of Business Development

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Merck & Co Inc	13,15%	0,23 Mrd. USD
2	ARK Investment Management LLC	7,44%	0,13 Mrd. USD
3	Ameriprise Financial Inc	7,11%	0,12 Mrd. USD
4	Lightspeed Management Co LLC	5,71%	0,10 Mrd. USD
5	BlackRock Inc	5,05%	0,09 Mrd. USD
6	T. Rowe Price Investment Management,Inc.	4,46%	0,08 Mrd. USD
7	Deep Track Capital, LP	3,75%	0,07 Mrd. USD
8	Aberdeen Group PLC	3,51%	0,06 Mrd. USD
9	Vanguard Capital Management, LLC	2,69%	0,05 Mrd. USD
10	Casdin Capital, LLC	2,39%	0,04 Mrd. USD
11	Kennedy Capital Management Inc	2,21%	0,04 Mrd. USD
12	AIGH Capital Management, LLC	1,61%	0,03 Mrd. USD
13	Blue Water Life Science Advisors, LLC	1,57%	0,03 Mrd. USD
14	T. Rowe Price Associates, Inc.	1,55%	0,03 Mrd. USD
15	Dimensional Fund Advisors, Inc.	1,40%	0,02 Mrd. USD
16	Geode Capital Management, LLC	1,22%	0,02 Mrd. USD
17	State Street Corp	1,06%	0,02 Mrd. USD
18	The Goldman Sachs Group Inc	0,69%	0,01 Mrd. USD
19	Portolan Capital Management, LLC	0,69%	0,01 Mrd. USD
20	JPMorgan Chase & Co	0,54%	0,01 Mrd. USD